ATRC
Price
$56.84Alerts
Change
+$0.86 (+1.54%)
Updated
Nov 13 closing price
Capitalization
2.98B
100 days until earnings call
Intraday BUY SELL Signals
TMCI
Price
$5.27Alerts
Change
-$0.07 (-1.31%)
Updated
Nov 13 closing price
Capitalization
262.09M
109 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ATRC vs TMCI

ATRC vs TMCI Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ATRC vs. TMCI commentary
Nov 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATRC is a Hold and TMCI is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for ATRC with price predictions
Nov 13, 2026

Momentum Indicator for ATRC turns negative, indicating new downward trend

ATRC saw its Momentum Indicator move below the 0 level on November 06, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 80 similar instances where the indicator turned negative. In 71 of the 80 cases, the stock moved further down in the following days. The odds of a decline are at 89%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for ATRC moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 30 similar instances where the indicator moved out of overbought territory. In 24 of the 30 cases, the stock moved lower in the following days. This puts the odds of a move lower at 80%.

The Moving Average Convergence Divergence Histogram (MACD) for ATRC turned negative on November 06, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 37 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 79%.

ATRC moved below its 50-day moving average on November 12, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ATRC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.

ATRC broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +9.44% 3-day Advance, the price is estimated to grow further. Considering data from situations where ATRC advanced for three days, in 212 of 301 cases, the price rose further within the following month. The odds of a continued upward trend are 70%.

The Aroon Indicator entered an Uptrend today. In 182 of 244 cases where ATRC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 75%.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 7 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 36 (best 1 - 100 worst), indicating steady price growth. ATRC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 88 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 92 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.766) is normal, around the industry mean (4.964). ATRC's P/E Ratio (266.091) is considerably higher than the industry average of (40.591). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (4.143). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (4.869) is also within normal values, averaging (56.876).

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ATRC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for TMCI with price predictions
Nov 13, 2026

TMCI in upward trend: 10-day moving average broke above 50-day moving average on November 02, 2026

The 10-day moving average for TMCI crossed bullishly above the 50-day moving average on November 02, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 11 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 82%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 09, 2026. You may want to consider a long position or call options on TMCI as a result. In 73 of 94 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 78%.

The Moving Average Convergence Divergence (MACD) for TMCI just turned positive on November 09, 2026. Looking at past instances where TMCI's MACD turned positive, the stock continued to rise in 35 of 43 cases over the following month. The odds of a continued upward trend are 81%.

TMCI moved above its 50-day moving average on November 09, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +9.43% 3-day Advance, the price is estimated to grow further. Considering data from situations where TMCI advanced for three days, in 204 of 266 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.

The Aroon Indicator entered an Uptrend today. In 126 of 162 cases where TMCI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 78%.

Bearish Trend Analysis

The 10-day RSI Indicator for TMCI moved out of overbought territory on October 30, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 24 similar instances where the indicator moved out of overbought territory. In 20 of the 24 cases, the stock moved lower in the following days. This puts the odds of a move lower at 83%.

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TMCI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.

TMCI broke above its upper Bollinger Band on October 26, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 24 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.869) is normal, around the industry mean (4.142). P/E Ratio (-4.380) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (1.430) is also within normal values, averaging (40.124).

The Tickeron Price Growth Rating for this company is 35 (best 1 - 100 worst), indicating steady price growth. TMCI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 38 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TMCI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

FUNDAMENTALS RATINGS
ATRC: Fundamental Ratings
ATRC
OUTLOOK RATING
1..100
81
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
88
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
7
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATRCTMCI
RSI
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
77%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
78%
MACD
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 11 days ago
70%
Bullish Trend 3 days ago
77%
Declines
ODDS (%)
Bearish Trend 5 days ago
82%
Bearish Trend 9 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 2 days ago
79%
Aroon
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
78%
COMPARISON
Comparison
Nov 15, 2026
Stock price -- (ATRC: $56.84 vs. TMCI: $5.27)
Brand notoriety: ATRC and TMCI are both not notable
ATRC represents the Pharmaceuticals: Other, while TMCI is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: ATRC: 46% vs. TMCI: 100%
Market capitalization -- ATRC: $2.98B vs. TMCI: $262.09M
ATRC [@Pharmaceuticals: Other] is valued at $2.98B. TMCI’s [@Medical/Nursing Services] market capitalization is $262.09M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $126 to $159.96B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $837 to $190.22B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $9.78B. The average market capitalization across the [@Medical/Nursing Services] industry is $6.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATRC’s FA Score shows that 1 FA rating(s) are green while TMCI’s FA Score has 1 green FA rating(s).

  • ATRC’s FA Score: 1 green, 4 red.
  • TMCI’s FA Score: 1 green, 4 red.
According to our system of comparison, TMCI is a better buy in the long-term than ATRC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATRC’s TA Score shows that 3 TA indicator(s) are bullish while TMCI’s TA Score has 6 bullish TA indicator(s).

  • ATRC’s TA Score: 3 bullish, 6 bearish.
  • TMCI’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, TMCI is a better buy in the short-term than ATRC.

Price Growth

ATRC (@Pharmaceuticals: Other) experienced а -2.90% price change this week, while TMCI (@Medical/Nursing Services) price change was +30.77% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +1.79%. For the same industry, the average monthly price growth was +4.31%, and the average quarterly price growth was +18.71%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +1.37%. For the same industry, the average monthly price growth was -4.49%, and the average quarterly price growth was -5.80%.

Reported Earning Dates

ATRC is expected to report earnings on Feb 23, 2027.

TMCI is expected to report earnings on Mar 04, 2027.

Industries' Descriptions

@Pharmaceuticals: Other (+1.79% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical/Nursing Services (+1.37% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

ATRC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATRC has been loosely correlated with CERS. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if ATRC jumps, then CERS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATRC
1D Price
Change %
ATRC100%
+1.54%
CERS - ATRC
42%
Loosely correlated
+2.32%
SIBN - ATRC
41%
Loosely correlated
-2.90%
IRMD - ATRC
38%
Loosely correlated
+0.38%
ICUI - ATRC
38%
Loosely correlated
+1.11%
TMCI - ATRC
37%
Loosely correlated
-1.31%
More

TMCI and

Correlation & Price change

A.I.dvisor indicates that over the last year, TMCI has been loosely correlated with UTMD. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if TMCI jumps, then UTMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TMCI
1D Price
Change %
TMCI100%
-1.31%
UTMD - TMCI
48%
Loosely correlated
-2.25%
GMED - TMCI
45%
Loosely correlated
-0.22%
CRL - TMCI
39%
Loosely correlated
-0.83%
AZTA - TMCI
39%
Loosely correlated
+4.08%
MTD - TMCI
39%
Loosely correlated
+0.46%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
WMTI21.510.31
+1.47%
REX WMT Growth & Income ETF
DWM73.860.17
+0.22%
WisdomTree International Equity Fund (DWM)
EZU67.290.06
+0.09%
iShares MSCI Eurozone ETF (EZU)
TSCV31.18-0.01
-0.02%
Thrivent Small Cap Value ETF (TSCV)
TSYY18.74-0.18
-0.97%
GraniteShares YieldBOOST TSLA ETF (TSYY)